Literature DB >> 15993237

The whole truth and nothing but the truth? The research that Philip Morris did not want you to see.

Pascal A Diethelm1, Jean-Charles Rielle, Martin McKee.   

Abstract

The tobacco industry maintained, for many years, that it was unaware of research about the toxic effects of smoking. By the 1970s, however, the industry decided that it needed this information but they were unwilling to seek it in a way that was open to public scrutiny. By means of material from internal industry documents it can be revealed that one company, Philip Morris, acquired a research facility, INBIFO, in Germany and created a complex mechanism seeking to ensure that the work done in the facility could not be linked to Philip Morris. In particular it involved the appointment of a Swedish professor as a 'co-ordinator', who would synthesise reports for onward transmission to the USA. Various arrangements were made to conceal this process, not only from the wider public, but also from many within Philip Morris, although it was known to some senior executives. INBIFO appears to have published only a small amount of its research and what was published appears to differ considerably from what was not. In particular, the unpublished reports provided evidence of the greater toxicity of sidestream than mainstream smoke, a finding of particular relevance given the industry's continuing denial of the harmful effects of passive smoking. By contrast, much of its published work comprises papers that convey a message that could be considered useful to the industry, in particular casting doubt on methods used to assess the effects of passive smoking.

Entities:  

Keywords:  Biomedical and Behavioral Research

Mesh:

Substances:

Year:  2005        PMID: 15993237     DOI: 10.1016/S0140-6736(05)66474-4

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  37 in total

1.  Sidestream cigarette smoke toxicity increases with aging and exposure duration.

Authors:  Suzaynn F Schick; Suzaynn Schick; Stanton A Glantz
Journal:  Tob Control       Date:  2006-12       Impact factor: 7.552

2.  A question of method. The ethics of managing conflicts of interest.

Authors:  Samia A Hurst; Alex Mauron
Journal:  EMBO Rep       Date:  2008-02       Impact factor: 8.807

Review 3.  Second-hand smoke and human lung cancer.

Authors:  Ahmad Besaratinia; Gerd P Pfeifer
Journal:  Lancet Oncol       Date:  2008-07       Impact factor: 41.316

4.  Do we believe the tobacco industry lied to us? Association with smoking behavior in a military population.

Authors:  Robert C Klesges; Deborah A Sherrill-Mittleman; Margaret Debon; G Wayne Talcott; Robert J Vanecek
Journal:  Health Educ Res       Date:  2009-06-15

5.  Type A behavior pattern and coronary heart disease: Philip Morris's "crown jewel".

Authors:  Mark P Petticrew; Kelley Lee; Martin McKee
Journal:  Am J Public Health       Date:  2012-09-20       Impact factor: 9.308

6.  Big tobacco "pull out all stops" for a landmark example: The Burswood Casino case.

Authors:  Bond Laura; Stafford Julia; Daube Mike
Journal:  Australas Med J       Date:  2011-12-31

Review 7.  Tobacco use among individuals with schizophrenia: what role has the tobacco industry played?

Authors:  Judith J Prochaska; Sharon M Hall; Lisa A Bero
Journal:  Schizophr Bull       Date:  2007-11-05       Impact factor: 9.306

8.  A framework for developing an evidence-based, comprehensive tobacco control program.

Authors:  Laura Rosen; Elliot Rosenberg; Martin McKee; Shosh Gan-Noy; Diane Levin; Elana Mayshar; Galia Shacham; John Borowski; Gabi Bin Nun; Boaz Lev
Journal:  Health Res Policy Syst       Date:  2010-05-27

9.  Who needs what from a national health research system: lessons from reforms to the English Department of Health's R&D system.

Authors:  Stephen Hanney; Shyama Kuruvilla; Bryony Soper; Nicholas Mays
Journal:  Health Res Policy Syst       Date:  2010-05-13

10.  Assessment of "gene-environment" interaction in cases of familial and sporadic pancreatic cancer.

Authors:  Theresa P Yeo; Ralph H Hruban; Jonathan Brody; Kieran Brune; Sheila Fitzgerald; Charles J Yeo
Journal:  J Gastrointest Surg       Date:  2009-05-21       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.